DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,395,000 | +2.6% | 47,988 | +0.7% | 0.54% | +9.0% |
| Q2 2022 | $12,076,000 | -15.1% | 47,633 | -1.8% | 0.49% | -3.9% |
| Q1 2022 | $14,231,000 | -10.2% | 48,515 | +0.7% | 0.51% | -6.6% |
| Q4 2021 | $15,844,000 | +8.2% | 48,157 | +0.1% | 0.55% | -1.3% |
| Q3 2021 | $14,640,000 | +12.0% | 48,089 | -1.2% | 0.55% | +8.2% |
| Q2 2021 | $13,066,000 | +18.1% | 48,690 | -0.9% | 0.51% | +7.8% |
| Q1 2021 | $11,063,000 | -3.2% | 49,153 | -4.4% | 0.48% | -7.8% |
| Q4 2020 | $11,424,000 | +1.7% | 51,426 | -1.4% | 0.52% | -7.5% |
| Q3 2020 | $11,236,000 | +18.7% | 52,181 | -2.5% | 0.56% | +5.9% |
| Q2 2020 | $9,463,000 | +22.4% | 53,515 | -4.2% | 0.53% | +3.7% |
| Q1 2020 | $7,734,000 | -9.9% | 55,876 | -0.1% | 0.51% | +12.2% |
| Q4 2019 | $8,581,000 | +6.2% | 55,908 | -0.1% | 0.45% | -3.2% |
| Q3 2019 | $8,081,000 | -2.4% | 55,951 | -3.4% | 0.47% | -5.1% |
| Q2 2019 | $8,278,000 | +8.3% | 57,919 | 0.0% | 0.49% | +3.8% |
| Q1 2019 | $7,646,000 | +24.1% | 57,919 | -3.0% | 0.47% | +10.2% |
| Q4 2018 | $6,159,000 | -4.5% | 59,727 | +0.6% | 0.43% | +8.9% |
| Q3 2018 | $6,451,000 | +9.1% | 59,371 | -0.9% | 0.40% | +4.2% |
| Q2 2018 | $5,912,000 | +0.4% | 59,910 | -0.4% | 0.38% | -2.1% |
| Q1 2018 | $5,888,000 | -0.3% | 60,135 | -5.5% | 0.39% | +6.0% |
| Q4 2017 | $5,905,000 | +12.6% | 63,614 | +4.1% | 0.36% | +5.2% |
| Q3 2017 | $5,243,000 | +4.9% | 61,127 | +3.2% | 0.35% | -14.1% |
| Q2 2017 | $4,999,000 | -2.7% | 59,238 | -1.4% | 0.40% | -6.9% |
| Q1 2017 | $5,137,000 | +9.0% | 60,058 | -0.8% | 0.43% | +4.1% |
| Q4 2016 | $4,711,000 | -1.3% | 60,526 | -0.6% | 0.42% | -4.1% |
| Q3 2016 | $4,775,000 | -23.5% | 60,916 | -1.5% | 0.44% | -24.9% |
| Q2 2016 | $6,244,000 | +5.8% | 61,825 | -0.6% | 0.58% | +2.7% |
| Q1 2016 | $5,900,000 | +0.5% | 62,196 | -1.6% | 0.56% | -1.4% |
| Q4 2015 | $5,868,000 | +6.0% | 63,181 | -2.7% | 0.57% | +0.2% |
| Q3 2015 | $5,534,000 | -0.1% | 64,950 | +0.3% | 0.57% | +15.4% |
| Q2 2015 | $5,540,000 | +0.6% | 64,725 | -0.2% | 0.50% | -6.6% |
| Q1 2015 | $5,508,000 | -2.6% | 64,876 | -1.7% | 0.53% | +5.4% |
| Q4 2014 | $5,657,000 | +10.6% | 66,001 | -2.0% | 0.50% | +7.2% |
| Q3 2014 | $5,115,000 | -7.8% | 67,322 | -3.5% | 0.47% | -6.8% |
| Q2 2014 | $5,545,000 | +4.8% | 69,797 | -1.1% | 0.50% | -2.7% |
| Q1 2014 | $5,292,000 | -8.9% | 70,557 | -6.2% | 0.52% | -12.5% |
| Q4 2013 | $5,810,000 | +9.7% | 75,257 | -1.5% | 0.59% | -2.6% |
| Q3 2013 | $5,295,000 | +7.9% | 76,382 | -1.4% | 0.61% | +0.7% |
| Q2 2013 | $4,906,000 | – | 77,497 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |